Competitors Scramble to Catch Up with Novartis in Radiopharmaceuticals Industry

Drug developers are optimistic about the potential of delivering radiation directly to tumors as a groundbreaking advancement in cancer treatment. Pharmaceutical giants like Bristol Myers Squibb, AstraZeneca, and Eli Lilly

Detail

Noom Introduces GLP-1 Drug Option in Innovative Weight Loss Program

Noom, a digital health company, has announced a new weight loss product featuring a compounded GLP-1 drug starting at $149. The treatment includes compounded semaglutide, the same active ingredient in

Detail

Lenacapavir by Gilead demonstrates 96% reduction in HIV infections in clinical trial.

A recent study has shown that Gilead’s new HIV prevention injectable drug, lenacapavir, has proven to reduce HIV infections by 96%. This positive phase-three trial data indicates the potential approval

Detail

Positive results from midstage trial of Pfizer’s cancer cachexia drug

Pfizer announced positive results from a midstage trial of its experimental drug for cancer cachexia, a condition that causes cancer patients to lose weight and appetite. The drug, ponsegromab, showed

Detail

Major Cost Savings and Product Launches Ahead: $1 Billion in Cuts, 10 New Products on the Horizon

Moderna announced plans to slash $1.1 billion in expenses by 2027 and introduce new products following a decline in its Covid business. The biotech company aims for 10 new product

Detail